Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19

Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19

The type 2 coronavirus causes severe acute respiratory syndrome (SARS-CoV-2) and produces pneumonia with pulmonary alveolar collapse. In some cases it also causes sepsis and septic shock. There is no specific treatment for coronavirus disease 2019 (COVID-19). Vitamin C (Vit C), Vitamin E (Vit E), N-...

Full description

Bibliographic Details
Main Authors: Adrián Palacios Chavarría, Rafael Ricardo Valdez Vázquez, José Guillermo Domínguez Cherit, Héctor Herrera Bello, Humberto Castillejos Suastegui, Lidia Moreno-Castañeda, Gabriela Alanís Estrada, Fabián Hernández, Omar González-Marcos, Huitzilihuitl Saucedo-Orozco, Linaloe Manzano-Pech, Ricardo Márquez-Velasco, Verónica Guarner-Lans, Israel Pérez-Torres, Maria Elena Soto
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
SARS-CoV-2
Antioxidants
Sepsis
COVID-19
Pneumonia
Interleukin
Online Access:http://www.sciencedirect.com/science/article/pii/S200103702100060X

Internet

http://www.sciencedirect.com/science/article/pii/S200103702100060X

Similar Items